[1] A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug-Drug-Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine

PBPK & PBBM

Pharmaceutics. 2020 Dec 8;12(12):1191.

Kanacher T, Lindauer A, Mezzalana E, Michon I, Veau C, Mantilla JD, Nock V, Fleury A.

External authors

Nock V,

Lindauer A,

Michon I,

Veau C,

Mantilla JD,

Fleury A

Pharmetheus collaborators